Nutraceuticals, Nutritional Therapy, Phytonutrients, and Phytotherapy for Improvement of Human Health: A Perspective on Plant Biotechnology Application

Recent Patents on Biotechnology

Volumn 1, Issue 1, 2007, Pages 75-97

  Zhao, Jian ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

clinical trial; metabolic engineering; Nutraceuticals; phytonutrients; plant biotechnology

Indexed keywords

BIOCONVERSION; CROPS; DISEASE CONTROL; METABOLITES; NUTRITION;

BIOTECHNOLOGY APPLICATIONS; CLINICAL TRIAL; CONCEPT SYSTEMS; HEALING SYSTEMS; HUMAN HEALTH; NATURAL PLANTS; NUTRACEUTICALS; NUTRITIONAL VALUE; PHYTONUTRIENT; PLANT BIOTECHNOLOGY;

METABOLIC ENGINEERING;

ANIMAL; BIOTECHNOLOGY; CHEMISTRY; DIET SUPPLEMENTATION; DIET THERAPY; DRUG APPROVAL; DRUG INDUSTRY; FOOD INDUSTRY; HUMAN; METABOLISM; METHODOLOGY; PATENT; PHYTOTHERAPY; PLANT; REVIEW; STANDARD; TRANSGENIC PLANT;

ANIMALS; BIOTECHNOLOGY; DIETARY SUPPLEMENTS; DRUG APPROVAL; DRUG INDUSTRY; FOOD INDUSTRY; HUMANS; NUTRITION THERAPY; PATENTS AS TOPIC; PHYTOTHERAPY; PLANTS; PLANTS, GENETICALLY MODIFIED;

EID: 54849419029     PISSN: 18722083     EISSN: 22124012     Source Type: Journal    
DOI: 10.2174/187220807779813893     Document Type: Article

References (297)

1. Bland JS. Phytonutrition, phytotherapy, and phytopharmacology. Altern Ther Health Med 1996; 2:73-76.
2. Berger MM, Shenkin A. Vitamins and trace elements: Practical aspects of supplementation. Nutrition 2006; 22:952-55.
3. Bagchi D. 2006. Nutraceuticals and functional foods regulations in the United States and around the world. Toxicol 2006; 221:1-3.
4. Ramaa CS, Shirode AR, Mundada AS, Kadam VJ. Nutra-ceuticals-an emerging era in the treatment and prevention of cardiovascular diseases. Curr Pharm Biotechnol 2006; 7:15-23.
5. Berger MM, Spertin F, Shenkin A, et al. Clinical, Immune and metabolic effects of trace element supplements in burns: A double-blind placebo-controlled trial. Clin Nutr 1996; 15:94-96.
6. Bagchi D, Preuss HG, Kehrer JP. Nutraceutical and functional food industries: aspects on safety and regulatory requirements, Toxicol Lett 2004; 150:1-2.
7. DeFelice SL. FIM. Rationale and proposed guidelines for the nutraceutical research & education act-NREA, November 10, 2002.
8. Zeisel SH. Regulation of “Nutraceuticals”. Science 1999; 285:185-86.
9. Whitman M. Understanding the perceived need for complementary and alternative nutraceuticals: lifestyle issues. Clin J Oncol Nurs 2001; 5: 190-94.
10. Koletzko B, Aggett PJ, Bindels JG, et al. Growth, development and differentiation: a functional food science approach. Br J Nutr 1998; 80(Suppl): 5-45.
11. Halsted CH. Dietary supplements and functional foods: 2 sides of a coin? Am J Clin Nutr 2003; 77: 1001S-1007S.
12. Ross S. Functional foods: the Food and Drug Administration perspective. Am J Clin Nut 2000; (Suppl)71: 1735-8.
13. Brower V. Nutraceuticals: poised for a healthy slice of the healthcare market? Nat Biotechnol 1998; 16: 728-731.
14. Gidley MJ. Naturally functional foods-challenges and opportunities. Asia Pac J Clin Nutr 2004; 13(Suppl): 31.
15. Shyur, L.F., Yang, N.S., Kang, P.L., Sun, S.J., Wang, S.Y.: US20047033617 (2004)
16. Fan, W., Bohlmann, J.A., Trinkle, J.R., Steinke, J.D., Hwang, K.O., Henning J.P.: US20037049433 (2003)
17. Falco, S.C., Cahoon, R.E., Hitz, W.D., Kinney, A.J., Rafalski, J.A.: US20026451581 (2002).
18. Udell, R.G.: US20060003947A1 (2006).
19. *[19] Wolfram, S., Loon van, L.J.C.: WO06077202A1 (2006) and EP1633208A1 (2006).
20. Romero, T., Miller, P.: WO06020091A3 (2006) and WO06020091A2 (2006).
21. Whittle, B., Hart, P.M.: WO06016170A3 (2006) and WO06016170A2 (2006).
22. *[22] Shen, B.J., Ghosh, P.: AU20020112A4 (2002), WO03062279A1 (2003), JP2005519914T2 (2005), EP1476471A1 (2004), CA2474269AA (2003); ZA0406621A (2004) and NZ0534760A (2005).
23. *[23] Raju, G.G.: US20050282894A1 (2005) and US20050282904A1 (2005).
24. Boreyko, B.K., Wang, Y.: US20050266018A1 (2005).
25. Garrity, A.R., Morton, J.C., Morrison, P., de la Huerga, V.: US20050196511A1 (2005), MX5004564A (2005) and EP1562619A2 (2005).
26. Triplett, D.G., Weatherspoon, J.B., Wang, P.Y.: US20050181105A1 (2005).
27. *[27] Mcgrew, G. N., Johnson, S.S., Record, D.W., Patel, M.M., Yatka, R.J., Greenberg, M.J., Witkewitz, D.L., Song, J.H.: US20056949264 (2005).
28. McKee, D., Karwic, A.: US20060134294A1 (2006) and WO06063219A2 (2006).
29. Andreoni, V., Benedtti, A., Canzi, E., Ciappellano, S., Fumagalli, M.: WO05118776A1 (2005) and EP1602716A1 (2005).
30. *[30] Pushpangadan, P., Prakash, D.: US20060147561A1 (2006) and US20037014872 (2003).
31. Bagchi, D.: US20060105965A1 (2006).
32. Gaudout, D., Megard, D., Inisan, C., Esteve, C., Lejard, F.: US20060073223A1 (2006) and US20037041322 (2003).
33. Butters, D.E., Davis, C.K.C., McGeary, R.P., Powanda, M.C., Rainsford, K.D., Whitehouse, M.W.: US20036761913 (2003) and US20026352728 (2002).
34. Cravotto, G.: US20050234127A1 (2005).
35. Matkin, J.R., Wang, S. Li, C., Huang, W.: US20060013842A1 (2006).
36. Watkins, J.M., Takaki, M.A.: WO06069020A1 (2006) and US20060134132A1 (2006).
37. Wahlqvist, M.L., Wattanapenpaiboon, N.: WO06053379A1 (2006).
38. Bell, S.J.D.: WO06050368A2 (2006) and WO06050836A3 (2006).
39. Centore, R., Berna, M., Giovannone, D.: WO06048911A3 (2006) and WO06048911A2 (2006).
40. Bagchi, D., Preuss, H.G., Kothari, S.C.: EP1438038A1 (2004) and EP1438038A4 (2004).
41. *[41] Mercati, V.: US20060147560A1 (2006).
42. Cha, A., Englenman, E.G.: WO06002096A2 (2006) and WO06002096A3 (2006).
43. Macfarlane, G., Macfarlane, S., Furrie, E., Cummings, J.: US20060115465A1 (2006).
44. McCleary, E.L.: US20060110477A1 (2006).
45. Chaung, H.C., Huang, C.S., Lee, F.Y., Lin, T.C.: US20060083799A1 (2006) and WO06020246A1 (2006).
46. Angellotti, C.: EP1607096A3 (2005) and EP1607096A2 (2005).
47. Mukhtar, H., Bhat, M.S.: US20060062745A2 (2006) and US20050201956A1 (2005).
48. *[48] Raederstoff, D., Teixeira, S.R., Weber, P.: CN1694695A (2005), US20060165671A1 (2006), WO04041257A2 (2004), JP2006508096T2 (2006) and AU3293592AH (2005).
49. *[49] Nafisi-Movaghar, K., Svanoe, T.T., Seroy, WA.: US5912363 (1999).
50. Darland, G.K., Lukaczer, D.O., Liska, D.J., Irving, T.A., Bland, J.S.: US6210701 (2001).
51. Ghai, G., Boyd, C., Csiszar, K., Ho, C.T., Rosen, R.T.: US5955269 (1999).
52. Lukaczer, D.O., Darland, G.K., Liska, D.J., Irving, T.A., Bland, J.S.: US6352712 (2002).
53. Guthrie, N., Kurowska, E.M., Manthey, J.A., Horowitz, S., Horowitz, R.M:. US20066987125 (2006).
54. Thomson A. Nutrition therapy in acute pancreatitis. JPEN J Parenter Enteral Nutr 2006; 30:536-37.
55. Schilter B, Andersson C, Anton R, et al. Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem Toxicol 2003; 41:1625-49.
56. Grunberger G, Jen KL, Artiss JD. The benefits of early intervention in obese diabetic patients with FBCx(trade mark)-a new dietary fibre. Diabetes Metab Res Rev. 2006. in press.
57. Moady, N., Moady, M.: US2006RE39199 (2006).
58. Pushpangadan, P., Rawat, A.K.S., Rao, C.V., Srivastava, S.K., Kharton, S.: US20060141069 A1 (2006).
59. Drieu, K., Papadopoulos, V.: US20067078434 (2006).
60. Kreuter, M.H., Wagner, H.K.M., Tittel, G.: US20047074436 (2004).
61. Jones, B.C., US20047060303 (2004).
62. Vail III, W.B. A., Vail, M.L.: US20047048953 (2004).
63. Thornton, S.P., Troyer, E.: US20067029712 (2006).
64. Romancyzk, Jr. L.J., Basak, A., Townsend, C.A.: US7015338 (2006).
65. *[65] Lin, C.H., Chuang, H.S.: US20047015248 (2004).
66. Trant, A.S.: US6989164 (2002).
67. Aleksandrovna, K.D., Gennad’evna, A.S., Viktorovna, G.A., Glebovich, P.V., Nikolaevnap, T., Leonidovna, Z.K., Viktorovna, N.J.: RU2276607C2 (2006).
68. *[68] Franchesko, D.P.: RU2274470C2 (2005), WO03013561A1 (2003), US20050008711A1 (2005), JP2005511494T2 (2005) and EP1414473B1 (2006).
69. Valentinovich, N.S., Anatol’evich, L.V., Dmitrievna, S.N., Vladimirovich, K.T.: RU2274469C2 (2005).
70. *[70] Cherukuri, R.S.V., Cherukuri, R.C., Cherukuri, A., Natarajan, K.: US20060083700A1 (2006).
71. Alekseevna, P.E.: RU2271215C1 (2006).
72. *[72] Tonikovich, O.E., Jur’evich, P.A., Andreevna, A.O., Grigor’evna, D.E., Sergeevnaa, Z., Olegovna, P.E.: RU2270686C2 (2006).
73. Kaloeva, T.V., Kaloeva, A.M.: RU2266127C2 (2005).
74. Agarval, R.K., Agarval, A.: RU2264224C2 (2005).
75. Mikhaljlova, T.M., Tankhaeva, L.M., Sambueva, Z.G., Olennikov, D.N., Tsyrenzhapov, A.V., Nikolaeva, G.G., Nikolaeva, S.M., Bodoev, N.V.: RU2264211C1 (2005).
76. Vutke, V.G., Jarri, K., Kristoffel, V., Shpengler, B., Pop, M:. RU2263505C2 (2002).
77. Theuer, R.C.: US20006051235 (2000).
78. Feldmann, M., Malfait, A.M., Gallily, R., Mechoulam, R.: US20026410588 (2002).
79. *[79] Wakabayashi, K., Moriyama, H.: US20026562793 (2002).
80. *[80] Paiva, N.L., Hipskind, J.D.: US20056974895 (2005).
81. Rapaka RS. Nutraceuticals, herbals and related products. Life Sci 2006; 78:2025.
82. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002; 76: 1191-201.
83. Plosch T, Kruit JK, Bloks VW, et al. Reduction of cholesterol absorption by dietary plant sterols and stanols in mice is independent of the Abcg5/8 transporter. J Nutr 2006; 136:2135-40.
84. Kris-Etherton PM, Hecker KD, et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 2002; 113(Suppl):71-88.
85. Hasler CM. Functional foods: benefits, concerns and challenges—a position paper from the American council on science and health, J. Nutr 2002; 132:3772-81.
86. Taylor CL. Regulatory frameworks for functional foods and dietary supplements. Nutr Rev 2004; 62:55-9.
87. Turner RE, Degnan FH, Archer DL. Label claims for foods and supplements: a review of the regulations. Nutr Clin Pract 2005 Feb; 20(1): 21-32.
88. Coppens P, da Silva MF, Pettman S. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety. Toxicol 2006; 221:59-74.
89. Ohama H, Ikeda H, Moriyama H. Health foods and foods with health claims in Japan. Toxicol 2006; 221:95-111.
90. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 2003; 27:355-73.
91. Rapaka RS, Coates PM. Dietary supplements and related products: a brief summary. Life Sci 2006; 78:2026-32.
92. Byham-Gray LD, Gilbride JA, Dixon LB, Stage FK Evidence-based practice: what are dietitians' perceptions, attitudes, and knowledge? J Am Diet Assoc 2005; 105:1574-81.
93. Atkinson SA. A nutrition odyssey: knowledge discovery, translation, and outreach. 2006 Ryley-Jeffs Memorial Lecture. Can J Diet Pract Res 2006; 67:150-6.
94. Perloff BP, Rizek RL, Haytowitz DB, Reid PR. Dietary intake methodology. II. USDA’s Nutrient Data Base for Nationwide Dietary Intake Surveys. J Nutr 1990; 120(Suppl): 1530-4.
95. Dwyer J, Picciano MF, Raiten DJ. Food and dietary supplement databases for What We Eat in America-NHANES. National Health and Nutrition Examination Survey. J Nutr 2003a; 133:624-34.
96. Dwyer J, Picciano MF, Raiten DJ; Collection of food and dietary supplement intake data: What We Eat in america-NHANES members of the steering committee; National Health and Nutrition examination survery. J Nutr 2003b; 133: 590-600.
97. Haggans CJ, Regan KS, Brown LM, Wang C, Krebs-Smith J, Coates PM, Swanson CA. 2005. Computer access to research on dietary supplements: a database of federally funded dietary supplement research. J Nutr 2005; 135:1796-99.
98. Gariballa S, Forster S, Walters S, Powers H. A randomized, double-blind, placebo-controlled trial of nutritional supplemen-tation during acute illness. Am J Med 2006; 119:693-99.
99. Gariballa SE, Parker SG, Taub N, Castleden CM. A randomized, controlled, a single-blind trial of nutritional supplementation after acute stroke. JPEN J Parenter Enteral Nutr 1998; 22:315-19.
100. Qin H, Li H, Xing M, Wu C, Li G, Song J. Nutritional support treatment for severe chronic hepatitis and posthepatitic cirrhosis. J Huazhong Univ Sci Technolog Med Sci 2006; 26:217-220.
101. Haiden N, Klebermass K, Cardona F, et al. A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics. 2006; 118: 180-188.
102. Pearce CB, Sadek SA, Walters AM, et al. A double-blind, randomised, controlled trial to study the effects of an enteral feed supplemented with glutamine, arginine, and omega-3 fatty acid in predicted acute severe pancreatitis. JOP 2006; 7: 361-371.
103. McAlindon TE. Nutraceuticals: do they work and when should we use them? Best Pract Res Clin Rheumatol 2006; 20:99-115.
104. Deal CL, Moskowitz RW. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999; 25:379-395.
105. Goggs R, Vaughan-Thomas A, Clegg PD, et al. Nutraceutical therapies for degenerative joint diseases: a critical review. Crit Rev Food Sci Nutr 2005; 45:145-164.
106. Ameye LG, Chee WS. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 2006; 8:127.
107. Donabedian H. Nutritional therapy and infectious diseases: a two-edged sword. Nutr J 2006; 5:21
108. McNaughton SA, Mishra GD, Paul AA, Prynne CJ, Wadsworth ME. Supplement use is associated with health status and health-related behaviors in the 1946 British birth cohort. J Nutr 2005; 35:1782-89.
109. Kattelmann KK, Hise M, Russell M, Charney P, Stokes M, Compher C. Preliminary evidence for a medical nutrition therapy protocol: enteral feedings for critically ill patients. J Am Diet Assoc 2006; 106:1226-41.
110. Iriti M, Faoro F. Grape phytochemicals: A bouquet of old and new nutraceuticals for human health. Med Hypotheses 2006; 67:833-38.
111. Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 1998; 95:3106-10.
112. Wiseman H, O’Reilly JD, Adlercreutz H, et al. TA. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 2000; 72:395-400.
113. Hallund J, Bugel S, Tholstrup T, et al. Soya isoflavone-enriched cereal bars affect markers of endothelial function in postmenopausal women. Br J Nutr 2006; 95:1120-26.
114. Stephens FO. Breast cancer: aetiological factors and associations (a possible protective role of phytoestrogens). Aust N Z J Surg 1997; 67:755-60.
115. Wagner H. Multitarget therapy-The future of treatment for more than just functional dyspepsia. Phytomedicine 2006; in press
116. Maxion-Bergemann S, Bornhoft G, Sonderegger E, Renfer A, Matthiessen PF, Wolf U. Traditional chinese medicine (phytotherapy): health technology assessment report-selected aspects. Forsch Komplementarmed 2006; 13(Suppl): 30-41.
117. Rosch W, Liebregts T, Gundermann KJ, Vinson B, Holtmann G. Phytotherapy for functional dyspepsia: A review of the clinical evidence for the herbal preparation STW 5. Phytomedicine 2006 in press.
118. Hijikata Y, Yasuhara A, Yoshida Y, Sento S. Traditional chinese medicine treatment of epilepsy. J Altern Complement Med 2006; 12:673-77.
119. Saxena VS, Venkateshwarlu K, Nadig P, et al. Multicenter clinical trials on a novel polyherbal formulation in allergic rhinitis. Int J Clin Pharmacol Res 2004; 24: 79-94.
120. Xue CC, Thien FC, Zhang JJ, Da Costa C, Li CG. Treatment for seasonal allergic rhinitis by Chinese herbal medicine: a randomized placebo controlled trial. Altern Ther Health Med 2003; 9:80-87.
121. Kaufeler R, Polasek W, Brattstrom A, Koetter U. Efficacy and safety of butterbur herbal extract Ze 339 in seasonal allergic rhinitis: postmarketing surveillance study. Adv Ther 2006; 23:373-84.
122. Couillard C, Pomerleau S, Ruel G, et al. Associations between hypertriglyceridemia, dietary fat intake, oxidative stress, and endothelial activation in men. Nutrition 2006; 22: 600-8.
123. Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB, Levy WC. Trans fatty acids and systemic inflammation in heart failure. Am J Clin Nutr 2004a; 80:1521-25.
124. Mozaffarian D, Pischon T, Hankinson SE, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004b; 79:606-12.
125. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005; 135:562-6.
126. Gennero L, Mortimer P, Sperber K, Carloni G, Ponzetto A. Stem cells: an alternative to organ transplantation in chronic, degenerative and infectious diseases? New Microbiol. 2006; 29:151-67
127. Bickford PC, Tan J, Shytle RD, Sanberg CD, El-Badri N, Sanberg PR. Nutraceuticals synergistically promote proliferation of human stem cells. Stem Cells Dev 2006; 15:118-23.
128. Conover EA. Over-the-counter products: nonprescription medications, nutraceuticals, and herbal agents. Clin Obstet Gynecol 2002; 45:89-98.
129. Demmelmair H, Von rosen J, Koletzko B. Long-term consequences of early nutrition. Early Hum Dev 2006; 82: 567-74.
130. Grusak MA, DellaPenna D. Improving the nutrient composition of plants to enhance human nutrition and health. Annu Rev Plant Physiol Plant Mol Biol 1999; 50:133-61.
131. Ye X, Al-Babili S, Kloti A, et al. Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 2000; 287:303-5
132. *[132] Potrykus, I., Beyer, P.: AU776160B2 (2004).
133. Grusak MA. Golden Rice gets a boost from maize. Nat Biotechnol 2005; 23:429-430.
134. Akobundu UO, Cohen NL, Laus MJ, Schulte MJ, Soussloff MN. Vitamins A and C, calcium, fruit, and dairy products are limited in food pantries. J Am Diet Assoc 2004 104:811-13.
135. Burgess C, O'connell-Motherway M, Sybesma W, Hugenholtz J, van Sinderen D. Riboflavin production in Lactococcus lactis: potential for in situ production of vitamin-enriched foods. Appl Environ Microbiol 2004; 70:5769-77.
136. Diaz de la Garza R, Quinlivan EP, Klaus SM, Basset GJ, Gregory JF 3rd, Hanson AD. Folate biofortification in tomatoes by engineering the pteridine branch of folate synthesis. Proc Natl Acad Sci USA 2004; 101:13720-25.
137. 12). Nat Prod Rep 2002; 19: 390-412.
138. Pinon V, Ravanel S, Douce R, Alban C. Biotin synthesis in plants. The first committed step of the pathway is catalyzed by a cytosolic 7-keto-8-aminopelargonic acid synthase. Plant Physiol 2005 139:1666-76.
139. Sybesma W, Burgess C, Starrenburg M, van Sinderen D, Hugenholtz J. Multivitamin production in Lactococcus lactis using metabolic engineering. Metab Eng 2004; 6:109-15.
140. Chen Z, Young TE, Ling J, Chang SC, Gallie DR. Increasing vitamin C content of plants through enhanced ascorbate recycling. Proc Natl Acad Sci USA 2003; 100:3525-3530.
141. Valentin HE, Qi Q. Biotechnological production and application of vitamin E: current state and prospects. Appl Microbiol Biotechnol 2005; 68:436-44.
142. Cahoon EB, Hall SE, Ripp KG, Ganzke TS, Hitz WD, Coughlan SJ. Metabolic redesign of vitamin E biosynthesis in plants for tocotrienol production and increased antioxidant content. Nat Biotechnol 2003; 21:1082-87.
143. 2+ transporters. Plant Physiol 2005; 139:1194-206.
144. Ma G, Jin Y, Piao J, Kok F, Guusje B, Jacobsen E. Phytate, calcium, iron, and zinc contents and their molar ratios in foods commonly consumed in China. J Agric Food Chem 2005; 53:10285-90.
145. Mehta RA, Cassol T, Li N, Ali N, Handa AK, Mattoo AK. Engineered polyamine accumulation in tomato enhances phytonutrient content, juice quality, and vine life. Nat Biotechnol 2002; 206:613-18.
146. Schijlen EG, de Vos R, Jonker H, et al. Pathway engineering for healthy phytochemicals leading to the production of novel flavonoids in tomato fruit. Plant Biotechnol J 2006; 4:433-44.
147. Hüsken A, Baumert A, Milkowski C, Becker HC, Strack D, Möllers C. Resveratrol glucoside (Piceid) synthesis in seeds of transgenic oilseed rape (Brassica napus L.). Theor Appl Genet 2005; 111: 1553-62.
148. Rein D, Schijlen E, Kooistra T, et al. Transgenic flavonoid tomato intake reduces C-reactive protein in human C-reactive protein transgenic mice more than wild-type tomato. J Nutr 2006; 136:2331-37.
149. Miller, G., Brown, L.A., Del Balzo, U., Flaim, S., Boddupalli, S., Wang, B.: US20027034054 (2002).
150. Guthrie, N., Kurowska, E.M., Manthey, J.A., Horowitz, S., Horowitz, R.M. US20066987125 (2006).
151. Rosenbloom, R.A.: US20047083813 (2004).
152. Romanczyk, Jr. L.J., Schmitz, H.H.: US20036998417 (2003).
153. Huang, R.: WO06026905A1 (2006).
154. Guthrie, N.: WO05115377B1 (2005) and WO05115377A1 (2005).
155. Fukumoto, S., Tsuruhami, K., Mori, S.: WO06070810A1 (2006).
156. Xu, G., Boyd, T.J., Hao, Z., Viscio, D., Gaffar, A., Mello, S.V., Arvanitidou, E.S., Prencipe, M.: WO06069210A2 (2006).
157. Trivedi, H.M., Xu,T.: WO06068973A2 (2006).
158. Han, B.H., Kang, S.S., Son, K.H.: WO06001665A1 (2006).
159. Rojas C.P.: WO06004386A1 (2006) and WO06004386C1 (2006).
160. *[160] Gutierrez-Uribe, J.A., Serna-Saldivar, S.R.O., Moreno-Cuevas, J.E., Hernandez-Brenes, C., Uajardo-Touche, E.M.: WO 05107780C1 (2005), US20060024394A1 (2006), WO 05107780A2 (2005) and WO05107780A3 (2005).
161. *[161] Caldwell, S.T., Bennett, C.J., Hartley, R.C., McPhail, D.B., Duthie, G.G.: U20060137207A1 (2006).
162. Nair, M.G., Wang, H., Strasburg, G.M., Booren, A.M., Gray, J.I.: US20036623743 (2003).
163. Tehoharides, T.C.: US20060013905A1 (2006).
164. Guthrie, N.: US20060013902A1 (2006).
165. Kelly,G.E.: US6987098 (2004).
166. Pandol, S.J., Gukovskaya, A.: US6953786 (2004) and WO05099721A2 (2005).
167. *[167] Guthrie, N.: US20060013861A1 (2006).
168. Johnson, C.D.: US20060040001A1 (2006) and WO 06014878A1(2006).
169. Zabrecky, G.: US7078064 (2005).
170. Koffas, M., Leonard, E., Yan, Y., Chemler, J.: WO06010117A2 (2006), WO06010117A3 (2006) and US20060019334A1(2006).
171. Dixon, R.A., Steele, C.L.: US7038113 (2006).
172. Spangenberg, G., Sawbridge, T.I., Ong, E.K., Emmerling, M.: NZ0531985A (2005).
173. Briskin, R.A.: US20067025994 (2006).
174. Cavazza, C.: EP1128822B1 (2001) and EP1128822A1 (2001).
175. Chan, P.K., Mak, M.S., Wand, Y.: US20050220910A1 (2005), WO05096704A3(2005), and WO05096704A2 (2005).
176. Rosenbloom, R.A.: US20050239721A1 (2005).
177. Sohpie, C.: GB0520247A0 (2005), GB2415905A1 (2006), WO04080474A1 (2004), US20050032882A1 (2005), DE10394175T5 (2006) and AU3269928AA (2004).
178. Liiek, B., Fischer, H.B.: EP1669067A2 (2006).
179. Rodriguez, G.C., Whitaker, R.S.: US20027053074 (2002).
180. Schwartz, G.K., Albino, A.P.: US20037045495 (2003).
181. Florio, V.V.: US20006136795 (2000).
182. Briskin, R.A.: US20067025994 (2006).
183. Romancyzk, Jr. L.J., Basak, A., Townsend, C.A.: US7015338 (2006).
184. Andrei, D.C.: RO0120531B1 (2001).
185. Andrei, C.; RO0120529B1 (2001).
186. Chen, S.: GB2415905A1 (2006).
187. Watkins, J.M., Takaki, M.A.: US20060134132 (2006).
188. Gutierrez-Uribe, J.A., Serna-Saldivar, S.R.O., Moreno-Cuevas, J.E., Hernandez-Brenes, C., Gutierrez-Uribe, J.: WO05107780A3 (2005) and WO05107780A2 (2005).
189. Udell, R.G., Israel, K.: US20060051435 (2006).
190. Ziegler, R.: US20050181076A1 (2005).
191. Miller, P.J., Steele, C., Kerr, K.: US20036903136 (2003).
192. Kahol, A.P., Singh, T., Tandon, S., Gupta, M.M., Khanuja, S.P.S.: US20046833143 (2004).
193. Mower, T.W., Harmon, M.C., Bawden, J.C., Banks, D.R,, Young, J.J.: US20060093685 (2006).
194. Pushpangadan, P., Prakash, D.: US20060147561 (2006).
195. Magnuson, B.A., Giusti, M.M., Malik, M., Zhao,C.: US20060159781 (2006).
196. Lotito SB, Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon? Free Radical Biol Med, 2006; in press.
197. Martin VJJ, Pitera DJ, Withers ST, Newman JD, Keasling JD. Engineering the mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 2003; 21: 1-7.
198. Aharoni A, Jongsma MA, Kim TY, et al. Metabolic engineering of terpenoid biosynthesis in plants. Phytochem Rev 2006; 5: 49-58.
199. Wildung MR, Croteau RB. Genetic engineering of peppermint for improved essential oil composition and yield. Transgenic Res 2005;14:365-72.
200. Takahashi S, Ogiyama Y, Kusano H, Shimada H, Kawamukai M, Kadowaki K. Metabolic engineering of coenzyme Q by modification of isoprenoid side chain in plant. FEBS Lett 2006; 580:955-59.
201. Romer S, Fraser PD, Kiano JW, et al. Elevation of the provitamin A content of transgenic tomato plants. Nat Biotechnol 2000; 18:666-69.
202. Romer S, Lubeck J, Kauder F, Steiger S, Adomat C, Sandmann G. Genetic engineering of a zeaxanthin-rich potato by antisense inactivation and co-suppression of carotenoid epoxidation. Metab Eng 2002; 4:263-72.
203. Giovannucci E. Tomatoes, tomato-based products, lycopene and cancer: review of the epidemiological literature. J Nat Cancer Inst 1999; 91:317-31.
204. Fraser PD, Bramley PM. The biosynthesis and nutritional uses of carotenoids. Prog Lipid Res 2004; 43:228-65.
205. Davuluri GR, van Tuinen A, Fraser PD, et al. Fruit-specific RNAi-mediated suppression of DET1 enhances carotenoid and flavonoid content in tomatoes. Nat Biotech 2005; 23:890-95.
206. Enfissi EMA, Fraser PD, Bramley PM. Genetic engineering of carotenoid formation in tomato. Phytochem Rev 2006; 5:59-65
207. Jeong, T.S., Lee, W.S., Kim, H.C., Choi, Y.K., Kim, J.R., An S.J., Im, K.R., Jang, K.C., Moon, O.S.: WO05084141A2 (2005) and WO05084141A3 (2005).
208. Coughlan, S.J.: US20067071381 (2006).
209. Ernst, H., Henrich, K., Keller, A.: US20060106257A1 (2006).
210. Andrei, C.: RO0120529B1 (2001).
211. Mechoulam, R., Maor, Y., Hanus, L., Horowitz, M.: WO05123051A3 (2005) and WO05123051A2 (2005)
212. *[212] Shewmaker, C.K., Bhat, B.G., Venkatramesh, M., Rangwala, S.H., Kishore, G.M., Boddupalli, S.S.: US20036653530 (2003)
213. Shewmaker, C.K.: US20026972351 (2002).
214. Hanada, M., Iwai, H., Fujigasaki, J.: US20026960350 (2002).
215. Wallace, W.H.: US20056949582 (2005).
216. Drake, R.G., Bird, C.R., Schuch, W.: WO9746690 (1997).
217. Innis SM. Essential fatty acids in growth and development. Prog Lipid Res 1986; 30: 39-103.
218. Uauy R, Treen M, Hoffman D. Essential fatty acid metabolism and requirements during development. Semin Perinatol 1989;13:118-30.
219. Psota TL, Gebauer SK, Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 2006; 98:3i-18i.
220. Singh SP, Zhou XR, Liu Q, Stymne S, Green AG. Metabolic engineering of new fatty acids in plants. Curr Opin Plant Biol 2005; 8:197-203.
221. Abbadi A, Domergue F, Bauer J, et al. Biosynthesis of very-long-chain polyunsaturated fatty acids in transgenic oilseeds: constraints on their accumulation, Plant Cell 2004; 16: 2734-48.
222. Qi B, Fraser T, Mugford S, et al. Production of very long chain polyunsaturated omega-3 and omega-6 fatty acids in plants, Nat Biotechnol 2004; 22:739-745.
223. Wu G, Truksa M, Datla N, et al. Stepwise engineering to produce high yields of very long-chain polyunsaturated fatty acids in plants. Nat Biotechnol 2005; 23:1013-7.
224. Windle EM Glutamine supplementation in critical illness: evidence, recommendations, and implications for clinical practice in burn care. J Burn Care Res 2006; 27:764-72.
225. Galili G, Karchi H, Shaul O, et al. Production of transgenic plants containing elevated levels of lysine and threonine. Biochem Soc Trans 1994; 22:921-5.
226. *[226] Kirihara, J.A., Hibberd, K.A., Anthony, J.: US20056960709 (2005) and US20060112443A1 (2006).
227. *[227] Anderson, P.C., Chomet, P.S., Griffor, M.C., Kriz, A.L.: US20026515201 (2002), US20006118047 (2000) and US20006118047 (2000).
228. *[228] Chieko, O., Yuji, J., Takao, K., Tetsuya, M., Daisuke, I.: US2002100074 (2002).
229. *[229] Chui, C.F.C., Falco, S.C., Rice, J.A., Knowlton, S.: US5939599 (1999).
230. De,C.A., Krebbers, E., Vandekerckhove, J., Gander, E., Van, M.M.: US5589615 (1996) and CA2000661 (2000).
231. Falco, S.C., Allen, S.M., Anderson, S.L., Rafalski, J.A.: US20026338966 (2002) and US20036548280 (2003).
232. Falco, S.C., Keeler, S.J., Rice, J.A.: US5559223 (1996).
233. *[233] Grimm, B., Tanaka, R.: US20036624342 (2003).
234. Falco, S.C., Keeler, S.J., Rice, J.A.: US5773691 (1998) and US20026459019 (2002).
235. Galili,G., Shaul,O., Perl, A.: US5367110 (1994).
236. Gengenbach, B.G., Somers, D.A., Bittel, D.C., Shaver, J.M., Sellner, J.M.: US5545545 (1996).
237. Glassman, K.F., Barnes, L.J., Pilacinski, W.P.: US5258300 (1993).
238. Hoffman, L.M.: US5576203 (1996).
239. Laberge, S., Vezina, L.P., Yelle, S., Benmoussa, M., Simard,R., Page, M.: CA2248396 (2000).
240. Lund, A.; WO06069017A2 (2006).
241. Warzecha H, Mason HS. Benefits and risks of antibody and vaccine production in transgenic plants. J Plant Physiol 2003; 160: 755-64.
242. Kirk DD, Webb SR. The next 15 years: taking plant-made vaccines beyond proof of concept. Immunol Cell Biol 2005; 83:248-56.
243. Lauterslager TG, Florack DE, van der Wal TJ, et al. Oral immunization of naive and primed animals with potato tubers expressing LTB. Vaccine 2001; 19: 2749-55.
244. Kapusta J, Modelska A, Figlerowicz M, et al. A plant-derived edible vaccine against hepatitis B virus. FASEB J 1999; 13:1796-9.
245. Richter LJ, Thanavala Y, Arntzen CJ, Mason HS. Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat Biotechnol 2000; 18:1167-71.
246. Sandhu JS, Krasnyanski SF, Domier LL, Korban SS, Osadjan MD, Buetow DE. Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Res 2000; 9:127-35.
247. Huang Z, Dry I, Webster D, Strugnell R, Wesselingh S. Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. Vaccine 2001; 19: 2163-71.
248. Tacket CO, Mason HS, Losonsky G, Estes MK, Levine MM, Arntzen CJ. Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes. J Infect Dis 2000; 182:302-5.
249. Yu J, Langridge WHR. 2001. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol 2001; 19:548-552.
250. Warzecha H, Mason HS. Benefits and risks of antibody and vaccine production in transgenic plants. J Plant Physiol 2003;160:755-764.
251. Ma JK, Hiatt A, Hein M, et al. Generation and assembly of secretory antibodies in plants. Science 1995; 268:716-719.
252. Ma JK. Genes, greens and vaccines. Nat Biotechnol 2000; 18:1141-42.
253. Staub JM, Garcia B, Graves J, et al. High yield of a human therapeutic protein in tobacco chloroplasts. Nat Biotechnol 2000; 18: 333-38.
254. Bakker H, Bardor M, Molthoff JW, et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proc Natl Acad Sci USA 2001; 98:2899-904.
255. *[255] Arakawa, T., Langridge, W.H.R., Yu, J.: WO0155169 (2001).
256. Brandle, J., Babiuk, L., Rymerson, R.: WO0194392 (2001).
257. Brandle, J., Erickson, L., Rymerson, R., Yoo, D., Zhang, J.: CA2221843 (1999).
258. Lam, D.M.K., Arntzen, C.J.: US5612487 (1997).
259. *[259] Curtiss, RIII, Cardineau G A US5654184 (1997), US5679880 (1997) and US5686079 (1997).
260. Boffey, S.A., Jones, H., Slater, R.J., Arokiaraj, P., Cheong, K.F., Wan, AR, Wan, Y., Yeang, H.Y.: US5580768 (1996).
261. Griot-Wenk, M.E., Goff, S.A., Heifertz, P.B., Tuttle, A.B.: WO0020612 (2002).
262. All, B.P., Howard, J.A.: US2002058312 (2002) and US20050166290A1 (2002).
263. Koprowski. H., Yusibov, V., Hooper, D.C., Modelska, A. US20006042832 (2000) and US20026448070 (2002).
264. Van Rooijen, G., Deckers, H., Heifertz, P.B., Briggs, S.P., Dalmia, B.K., Del Val, G., Zaplinski, S., Moloney, M.: WO0250289 (2002).
265. Russell DR, Fuller, J.T, Miller, M.J. US20006140075 (2000).
266. Russell DR, Fuller, J.T US20006080560 (2000).
267. Lam, D. M., Arntzen, C. J., US5484719 (1996).
268. McCormick, A.A., Tuse, D., Reinl, S.J., Lindbo, J.A., Turpen, T.H.: US20037084256 (2003)
269. Daniell, H.: US20030204864A1 (2006).
270. Langridge, W.H.R., Arakawa, T.: US20020055618A1 (2002) and US20050044588A1(2005).
271. *[271] Arntzen, C.J., Lam, D.M.K.: US20030138456A1 (2003), US20050232949A1 (2005), US20040166121A1 (2004) and US20010053367A1 (2001).
272. Buetow, D.E., Korban, S.S., Sandhu, J., Krasnyanski, S.F.: US20050129704A1 (2005).
273. *[273] Daniell, H.: US20060117412A1 (2006).
274. Seki, T. Fujiyama, K. US6998267 (2006).
275. *[275] Hein, M.B., Hiatt, A.: US20067037722 (2006), US20067005560 (2006), US6995014 (2006) and US20026417429 (2002).
276. Hein, M.B., Hiatt, A.C. Fitchen JH.: US20016251392 (2001).
277. Hein, M.B., Hiatt, A, Ma, J.K.C. EP946717A1 (1999), WO9742313A1 (1997), CA 2253454AA(1996) and US5959177 (1999).
278. Hein, M.B., Hiatt, A.C.: US7101688 (2003).
279. Hein, M.B., Hiatt, A.C.: Fitchen JH.: US20026440419 (2002).
280. Hein, M.B., Hiatt, A.C.: Fitchen JH.: WO9920310A1 (1999).
281. Hall, G., Bascomb, N., Bossie, M.: WO02101006 (2002).
282. Conrad, U, Fieldler, U, Phillips, J, Artsaenko, O., US6403371 (2002), WO972900A1 (1997).
283. Van Rooijen, G., Deckers, H., Heifertz, P.B., Briggs, S.P., Dalmia, B.K., Del Val, G., Zaplinski, S., Moloney, M.: WO0250289 (2002).
284. *[284] Russell, D.R., Fuller, J.T., Miller, M.J.: US20006140075 (2000).
285. Russell, D.R., Fuller, J.T.: US20006080560 (2000).
286. Lehner, T., Ma, J.K.C, Hiatt, A.C.: CA2208783AA (1996).
287. *[287] Hiatt A.C., Ma. J.K.C., Lehner, T., Mostov, K.E.: US20006046037 (2000), WO9621012A1 (1996), EP8207173A1 (1997), and CA2209783AA (1996).
288. Hiatt A.C., Hein, M.B., Fitchen, J.H.: US20006391280 and US20006045774 (2000).
289. McDonald, K.A; Jackman, A.P., Trexler, M.: US20027045354 (2002).
290. Hiatt, A.C., Hein, M.B.: US5639947 (1997).
291. Hiatt, A.C., Hein, M.B.: US5202422 (1993).
292. Huang, N., Rodriguez, R.L., Hagie, F.E.: US20036991824(2003).
293. During A, Harrison E.H. Intestinal absorption and metabolism of carotenoids: insights from cell culture. Arch Biochem Biophys 2004; 430:77-88.
294. Tang G, Qin J, Dolnikowski, GG, Russell RM, Grusak MA. Spinach or carrots can supply significant amounts of vitamin A as assessed by feeding with interisically deuterated vegetables. Am J Clin Nutr 2005; 82: 821-828.
295. Kroes R, Walker R. Safety issues of botanicals and botanical preparations in functional foods. Toxicol 2004; 198:213-220.
296. Roy C, Rink, Khanna S, et al. Body weight and abdominal fat gene expression profile in response to a novel hydroxycitric acid-based dietary supplement. Gene Exp 2004; 11:251-262.
297. Acosta PB, Yannicelli S, Ryan AS, et al. Nutritional therapy improves growth and protein status of children with a urea cycle enzyme defect. Mol Genet Metab 2005; 86:448-455.